Corpus Intelligence IC Memo — CURRY HEALTH DISTRICT 2026-04-26 06:42 UTC
IC Memo — CURRY HEALTH DISTRICT
Investment Committee Memorandum | OR | 16 beds | Grade C | EBITDA uplift $4.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CURRY HEALTH DISTRICT

CCN 381322 | CURRY, OR | 16 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CURRY HEALTH DISTRICT is a 16-bed suburban community hospital in CURRY, OR with $66.3M in net patient revenue and a 0.5% operating margin. The hospital serves a payer mix of 54.8% Medicare, 1.2% Medicaid, and 44.0% commercial.

Thesis: Turnaround. Our ML models identify $4.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.5% to 7.8% (+736bps).

Net Revenue HCRIS$66.3M
Current EBITDA COMPUTED$320K
Operating Margin COMPUTED0.5%
Occupancy HCRIS45.8%
Revenue / Bed COMPUTED$4.1M
Net-to-Gross HCRIS54.5%
Distress Probability ML47.6%

2. Market Context & Competitive Position

63
OR Hospitals
-8.1%
State Median Margin
23
Comparable Hospitals

OR has 63 Medicare-certified hospitals with a median operating margin of -8.1%. The target's margin of 0.5% places it above the state median. Among 23 size-comparable peers (8-32 beds), the median margin is -5.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-32), prioritizing same-state peers. 23 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CURRY HEALTH DISTRICT (Target)OR16$66.3M0.5%
GOOD SHEPHERD MEDICAL CENTEROR25$177.5M5.3%
COLUMBIA MEMORIAL HOSPITALOR25$165.9M5.2%
SAMARITAN LEBANON COMM HOSPITAOR25$157.9M3.9%
SAMARITAN PACIFIC COMM HOSPITAOR25$141.7M3.7%
GRANDE RONDE HOSPITALOR25$134.8M-4.1%
SILVERTON HOSPITALOR29$118.4M-16.1%
HOOD RIVER MEMORIAL HOSPITALOR25$113.0M-11.6%
TILLAMOOK REGIONAL MEDICAL CENOR25$106.7M3.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.4M+210bp18mo
Cost to Collect4.5%2.5%$1.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$807K+122bp9mo
Clean Claim Rate88.0%96.0%$42K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.4M
Cost to Collect
$1.3M
Denial Rate Reduction
$1.3M
A/R Days Reduction
$807K
Clean Claim Rate
$42K
Total EBITDA Uplift$4.9M
Current EBITDA$320K
+ RCM Uplift+$4.9M
Pro Forma EBITDA$5.2M
Current Margin0.5%
Pro Forma Margin7.8%
WC Released (1x)$2.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$493K$50.9M103.35x152.8%
Base (11x exit)10.0x11.0x$493K$56.2M114.01x157.9%
Bull Case9.0x11.0x$443K$72.4M163.36x177.1%
Bull (12x exit)9.0x12.0x$443K$79.1M178.51x182.1%
Bear Case11.0x10.0x$542K$26.4M48.63x117.5%
Bear (11x exit)11.0x11.0x$542K$29.2M53.82x121.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 23 hospitals with 8-32 beds
  • Same-state prioritization (n=24)
  • Comp margins: P25=-13.9% / P50=-5.5% / P75=3.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.